Amy Schell, MD, is an assistant professor in the Department of Otolaryngology – Head and Neck Surgery. She carries a second appointment in the Department of Medicine – Division of Pulmonary, Critical Care, and Sleep Medicine and is the director of the UH Inspire Program. She is an Erie, Pa., native and joined University Hospitals in August 2018.
Dr. Schell is board certified in otolaryngology and board eligible in sleep medicine. She has special interest in the medical and surgical treatments for obstructive sleep apnea (OSA) and snoring.
She is a member of the American Academy of Otolaryngology, the Triological Society, the American Academy of Sleep Medicine, and the International Surgical Sleep Society.
Dr. Schell’s research interests include upper airway neurostimulation therapy, the role of the nasal airway in snoring and OSA, and the various physiologic and anatomic phenotypes associated with OSA.
Dr. Schell has a Bachelor of Science in biomedical engineering from the University of Virginia, where she also stayed to earn her medical degree. She completed her otolaryngology residency and sleep medicine fellowship at the University of Pittsburgh Medical Center in Pittsburgh.
University Suburban Health Center
1611 S Green Rd
South Euclid OH, 44121
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood OH, 44122
Patient Satisfaction Reviews
4.8 out of 5
- Otolaryngology - American Board of Otolaryngology
Fellowship | Sleep Medicine - Otolaryngology
Sleep Medicine - Otolaryngology - Upmc Montefiore (2017 - 2018)
Residency | Otolaryngology
Otolaryngology - Upmc Eye And Ear Institute (2012 - 2017)
University Of Virginia School Of Medicine (2012)
University Of Virginia (2008)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Amy Schell did not disclose any Outside Relationships with Industry.